Pneumatic Nebulizer Market - Growth, Trends, and Forecasts (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||946303|
|出版日期||內容資訊||英文 117 Pages
|氣動霧化器市場增長，趨勢，預測（2020-2025） Pneumatic Nebulizer Market - Growth, Trends, and Forecasts (2020 - 2025)|
|出版日期: 2020年06月01日||內容資訊: 英文 117 Pages||
The pneumatic nebulizer market is expected to register a 5.3 % of CAGR over the forecast period. The increasing number of cases of respiratory diseases and increasing geriatric population is expected to drive the market growth. According to the Global Burden of Disease Study, the prevalence of chronic pulmonary respiratory diseases (COPD) was found to be around 251 million and more than 90% of the COPD deaths occure in low- and middle-income countries. Hence, with the rising adoption of homecare devices by the patients it is expected to fuel the pneumatic nebulizer market growth.
Portable Pneumatic Nebulizer is Expected to Exhibit a Significant Market Growth Over the Forecast Period
Portable pneumatic nebulizer is expected to show a robust growth owing to the rising prevalence of respiratory diseases such as asthma and COPD and increasing geriatric population. The rising adoption of portable nebulizer due to its convenience and effectiveness is expected to influence positively on the growth. According to the study of Analytica Chimica Acta, 2020, pneumatic nebulizer was used for introducing metallic ionic meta callibrant solutions and nanoparticles. Furthermore, according to the World Health Organization, currently there are approximately 339 million people in the world living with asthma and over 80% of these reside in low- and middle- income countries. Hence, these factors are expected to impact positiviely on the market growth.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to be a dominant region in the Pneumatic Nebulizer market owing to higher prevalence of respiratory diseases and increasing geriatric population. According to the Centre for Disease Control and Prevention, in 2017, prevalence of asthma in male was found to be approximately 6.4% and 9.3% in female in the United States. Moreover, according to the U.S. Department of Health and Human Services, around 33,401 Americans suffered from emphysema in 2018. This is expected to increase the demand for pneumatic nebulizers and thereby propelling the market growth.
Some of the well-known compaies in Pneumatic Nebulizer market inlcude Aerogen, Heyer Medical AG, GE Healthcare, Agilent Technologies, Salter Labs, Medline Industries Inc., Briggs Healthcare, PARI Pharma and Omron Healthcare.